pdufa.bio

Mecbotamab Vedotin

Updated ยทnext FDA decision on the calendar

Mecbotamab Vedotin 1 FDA decision on record below. Every date links its source.

BCAB catalyst hub

About this program

We track 1 catalyst event for this program: 0 upcoming and 1 in the record. A PDUFA date is the FDA's target date to complete review of a marketing application; a readout is the sponsor's expected date for clinical trial results. What a PDUFA date is · why we do not compare trial results across drugs.

Catalyst history

PDUFA · Nov 7, 2025 ✓ ApprovedBCAB

Questions

When is Mecbotamab Vedotin's next FDA decision or readout?

No upcoming catalyst is on our calendar for Mecbotamab Vedotin; 1 FDA decision is on record below.

What happened at Mecbotamab Vedotin's most recent FDA decision?

On Nov 7, 2025 the FDA approved the application. The decision page carries the source document and the measured share-price reaction.

Has Mecbotamab Vedotin been approved by the FDA?

Yes. The FDA approved an application for Mecbotamab Vedotin on Nov 7, 2025; the decision page linked above carries the source.

Where does this data come from?

FDA announcements, sponsor press releases and SEC filings; every date on this page links its source.